Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > People selling taking profits today that bought in.17 to .22
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(52)
•••
Comment by MiningGospelon Aug 24, 2021 1:37am
148 Views
Post# 33753439

RE:RE:RE:RE:RE:RE:RE:RE:People selling taking profits today that bought in.17 to .22

RE:RE:RE:RE:RE:RE:RE:RE:People selling taking profits today that bought in.17 to .22Wtf do you keep going on about Syqe, they have a device ONLY not a properly-dosed drug/device combo like TBP. A doctor cannot prescribe someone a Syqe vaporizer but they will be able to prescribe QIXLEEF/mighty medic combo if it makes it through clinical trials. They are NOT the same because dosage/pharma quality of the DRUG is what matters the most. Get it through your head
SamV21 wrote: Sounds to me like they are almost at the same stag with Syqe ahead with health Canada approval and FDA approvals in other countries.Neither devices have FDA approval in the US .Once Tetra gets through phase 2 maybe things will change , one can only hope so, chances are not much gain for tetra on the device end  using another companies device, only the product that goes into the device.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities